The potential off-target effects of siRNAs51 and γ-secretase inhibition that affect both NOTCH1 and NOTCH248,49 expression can account for the increased cell proliferation and invasive capacity of bladder cancer cells. The gene discussed is NOTCH1; the disease is urinary bladder cancer.